Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
Clinical trial NCT05055687 · COMPLETED
Trial details
- NCT number
- NCT05055687
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-05
- Primary completion
- 2020-07-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.